Bogle Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,575
Closed -$3.28M 158
2020
Q3
$3.28M Sell
11,575
-4,926
-30% -$1.37M 0.96% 13
2020
Q2
$4.42M Sell
16,501
-21,741
-57% -$6.54M 0.73% 41
2020
Q1
$12.1M Sell
38,242
-10,898
-22% -$3.31M 1.26% 1
2019
Q4
$14.6M Sell
49,140
-5,860
-11% -$1.63M 1.36% 6
2019
Q3
$12.8M Hold
55,000
1.1% 18
2019
Q2
$12.9M Hold
55,000
1.01% 27
2019
Q1
$13M Buy
+55,000
New +$17.3M 1% 22
2018
Q4
Sell
-39,300
Closed -$13.9M 334
2018
Q3
$13.9M Buy
+39,300
New +$13.5M 1% 36
2017
Q2
Sell
-40,019
Closed -$10.9M 304
2017
Q1
$10.9M Buy
+40,019
New +$11.3M 0.76% 60
2016
Q4
Sell
-35,011
Closed -$11M 334
2016
Q3
$11M Sell
35,011
-15,604
-31% -$4.62M 0.79% 38
2016
Q2
$12.2M Buy
50,615
+5,815
+13% +$1.53M 0.85% 33
2016
Q1
$11.7M Buy
+44,800
New +$11.8M 0.78% 47
2015
Q2
Sell
-36,152
Closed -$15.3M 360
2015
Q1
$15.3M Sell
36,152
-148
-0.4% -$58.3K 1.05% 13
2014
Q4
$12.3M Buy
36,300
+2,900
+9% +$938K 0.82% 29
2014
Q3
$11M Buy
+33,400
New +$11M 0.72% 64
2013
Q3
Sell
-26,100
Closed -$5.62M 307
2013
Q2
$5.62M Buy
+26,100
New +$5.58M 0.69% 52

Other funds holding BIIB

Bogle Investment Management's BIIB Position: Q4 2020 in Review

Bogle Investment Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 11,575 shares — an estimated $3.28M sold.

Bogle Investment Management first reported a position in BIIB in Q2 2013 and held it in 16 quarters. The position peaked at $15.3M in Q1 2015. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Bogle Investment Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Bogle Investment Management sold 11,575 Biogen shares in Q4 2020, an estimated $3.28M.
  • Bogle Investment Management first reported a position in Biogen in Q2 2013 and held it in 16 quarters.
  • Bogle Investment Management's Biogen position peaked at $15.3M in Q1 2015.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.